1. Home
  2. FGEN vs CPSH Comparison

FGEN vs CPSH Comparison

Compare FGEN & CPSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • CPSH
  • Stock Information
  • Founded
  • FGEN 1993
  • CPSH 1984
  • Country
  • FGEN United States
  • CPSH United States
  • Employees
  • FGEN N/A
  • CPSH N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • CPSH Building Materials
  • Sector
  • FGEN Health Care
  • CPSH Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • CPSH Nasdaq
  • Market Cap
  • FGEN 33.5M
  • CPSH 36.6M
  • IPO Year
  • FGEN 2014
  • CPSH 1987
  • Fundamental
  • Price
  • FGEN $7.45
  • CPSH $2.53
  • Analyst Decision
  • FGEN Strong Buy
  • CPSH
  • Analyst Count
  • FGEN 1
  • CPSH 0
  • Target Price
  • FGEN $250.00
  • CPSH N/A
  • AVG Volume (30 Days)
  • FGEN 48.5K
  • CPSH 63.0K
  • Earning Date
  • FGEN 08-05-2025
  • CPSH 08-04-2025
  • Dividend Yield
  • FGEN N/A
  • CPSH N/A
  • EPS Growth
  • FGEN N/A
  • CPSH N/A
  • EPS
  • FGEN N/A
  • CPSH N/A
  • Revenue
  • FGEN $6,996,000.00
  • CPSH $22,716,633.00
  • Revenue This Year
  • FGEN N/A
  • CPSH N/A
  • Revenue Next Year
  • FGEN N/A
  • CPSH N/A
  • P/E Ratio
  • FGEN N/A
  • CPSH N/A
  • Revenue Growth
  • FGEN N/A
  • CPSH N/A
  • 52 Week Low
  • FGEN $4.50
  • CPSH $1.27
  • 52 Week High
  • FGEN $33.49
  • CPSH $3.18
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 55.79
  • CPSH 46.47
  • Support Level
  • FGEN $7.31
  • CPSH $2.45
  • Resistance Level
  • FGEN $7.82
  • CPSH $2.68
  • Average True Range (ATR)
  • FGEN 0.59
  • CPSH 0.21
  • MACD
  • FGEN 0.10
  • CPSH -0.02
  • Stochastic Oscillator
  • FGEN 69.35
  • CPSH 56.58

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About CPSH CPS Technologies Corp.

CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.

Share on Social Networks: